Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Alexza Pharmaceuticals LLC is active in the Medical Devices & Mechanical Engineering technology area. The portfolio currently contains 3 pending office actions. These actions are assigned to 3 distinct examiners across 2 distinct art units, showing a relatively focused review process for the company's mechanical innovations.
The busiest examiner for the company is FUBARA, BLESSING M, who handles 1 busiest examiner pending action. Because there are 3 pending office actions, each of the 3 distinct examiners is responsible for one matter. The involvement of 2 distinct art units suggests that the medical device and mechanical engineering claims are being processed by a small, specific set of technical groups. This concentration within 2 distinct art units may provide some consistency in the technical standards applied to the 3 pending actions, despite the involvement of 3 different examiners.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FUBARA, BLESSING M | 1 | 62.2% | +34.1% |
| LEDERER, SARAH B | 1 | 55.6% | +36.9% |
| BUGG, PAIGE KATHLEEN | 1 | 58.5% | +59.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18743451 | HANDHELD MEDICAL DEVICE WITH IMPROVED DELIVERY OF AEROSOL PARTICLES | LEDERER, SARAH B | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17079365 | USE OF ANTISTATIC MATERIALS IN THE AIRWAY FOR THERMAL AEROSOL CONDENSATION PROCESS | BUGG, PAIGE KATHLEEN | 70d |
| 18912420 | METHOD OF TREATING EPILEPSY | FUBARA, BLESSING M | — |
| 18743451 | HANDHELD MEDICAL DEVICE WITH IMPROVED DELIVERY OF AEROSOL PARTICLES | LEDERER, SARAH B | — |
| Art Unit | Apps |
|---|---|
| 3785 | 2 |
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18912420 | METHOD OF TREATING EPILEPSY | FUBARA, BLESSING M | 1613 | §103DP | Non-Final OA | — | Pending | Oct 10, 2024 |
| 18743451 | HANDHELD MEDICAL DEVICE WITH IMPROVED DELIVERY OF AEROSOL PARTICLES | LEDERER, SARAH B | 3785 | §103§112 | Non-Final OA | — | Pending | Jun 14, 2024 |
| 17079365 | USE OF ANTISTATIC MATERIALS IN THE AIRWAY FOR THERMAL AEROSOL CONDENSATION PROCESS | BUGG, PAIGE KATHLEEN | 3785 | §103 | Final Rejection | 70d | Pending | Oct 23, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAlexza Pharmaceuticals LLC has 3 pending office actions as of October 2026, spread across 2 art units and 3 examiners.
Blessing M Fubara has the most, with 1 of Alexza Pharmaceuticals LLC's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
